AIM ImmunoTech Statistics

Total Valuation

AIM ImmunoTech has a market cap or net worth of $12.12 million. The enterprise value is $8.32 million.

Market Cap	12.12M
Enterprise Value	8.32M

Important Dates

The last earnings date was Friday, November 15, 2024, before market open.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

AIM ImmunoTech has 63.78 million shares outstanding. The number of shares has increased by 7.96% in one year.

Current Share Class	63.78M
Shares Outstanding	63.78M
Shares Change (YoY)	+7.96%
Shares Change (QoQ)	+9.16%
Owned by Insiders (%)	9.23%
Owned by Institutions (%)	7.34%
Float	57.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	52.24
Forward PS	n/a
PB Ratio	3.83
P/TBV Ratio	31.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	43.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.75, with a Debt / Equity ratio of 1.17.

Current Ratio	0.75
Quick Ratio	0.71
Debt / Equity	1.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-61.64

Financial Efficiency

Return on equity (ROE) is -187.58% and return on invested capital (ROIC) is -117.65%.

Return on Equity (ROE)	-187.58%
Return on Assets (ROA)	-84.20%
Return on Capital (ROIC)	-117.65%
Revenue Per Employee	$6,786
Profits Per Employee	-$854,607
Employee Count	28
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.92% in the last 52 weeks. The beta is -0.40, so AIM ImmunoTech's price volatility has been lower than the market average.

Beta (5Y)	-0.40
52-Week Price Change	-61.92%
50-Day Moving Average	0.23
200-Day Moving Average	0.34
Relative Strength Index (RSI)	35.49
Average Volume (20 Days)	376,455

Short Selling Information

The latest short interest is 491,374, so 0.77% of the outstanding shares have been sold short.

Short Interest	491,374
Short Previous Month	590,329
Short % of Shares Out	0.77%
Short % of Float	0.85%
Short Ratio (days to cover)	1.63

Income Statement

In the last 12 months, AIM ImmunoTech had revenue of $190,000 and -$23.93 million in losses. Loss per share was -$0.46.

Revenue	190,000
Gross Profit	154,000
Operating Income	-27.92M
Pretax Income	-31.12M
Net Income	-23.93M
EBITDA	-27.68M
EBIT	-27.92M
Loss Per Share	-$0.46

Full Income Statement

Balance Sheet

The company has $7.20 million in cash and $3.40 million in debt, giving a net cash position of $3.80 million or $0.06 per share.

Cash & Cash Equivalents	7.20M
Total Debt	3.40M
Net Cash	3.80M
Net Cash Per Share	$0.06
Equity (Book Value)	2.91M
Book Value Per Share	0.05
Working Capital	-2.53M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$20.69 million and capital expenditures -$8,000, giving a free cash flow of -$20.70 million.

Operating Cash Flow	-20.69M
Capital Expenditures	-8,000
Free Cash Flow	-20.70M
FCF Per Share	-$0.32

Full Cash Flow Statement

Margins

Gross Margin	81.05%
Operating Margin	-14,695.26%
Pretax Margin	-12,594.21%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AIM ImmunoTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.96%
Shareholder Yield	-7.96%
Earnings Yield	-197.47%
FCF Yield	-170.81%

Analyst Forecast

The average price target for AIM ImmunoTech is $2.75, which is 1,347.37% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.75
Price Target Difference	1,347.37%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	189.24%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 11, 2019. It was a reverse split with a ratio of 0.022727273:1.

Last Split Date	Jun 11, 2019
Split Type	Reverse
Split Ratio	0.022727273:1

Scores

AIM ImmunoTech has an Altman Z-Score of -49.17 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-49.17
Piotroski F-Score	2